Christine Bellon, CLO of Beam Therapeutics BEAM, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $881K. The latest trade was on 04/01.

CB

CB

Christine Bellon

Chief Legal Officer

Company

Beam Therapeutics BEAM

First filing

23/03/31

Trades

37 trades

Buys / sales

0 / 18

12-month net buying

−$881K

Last trade

04/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	04/01	04/06	5,956 sh	$24.58	$146,398.48	−5.1%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	01/22	01/26	1,371 sh	$34.00	$46,614	−1.4%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	01/15	01/20	18,629 sh3 trades	$34.62avg.	$644,856.9	−16.1%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	25/12/31	01/05	1,254 sh	$27.10	$33,983.4	−1.1%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	25/10/01	25/10/03	373 sh	$24.53	$9,149.69	−0.3%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	25/04/01	25/04/03	5,674 sh	$18.35	$104,117.9	−4.6%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	25/02/14	25/02/19	10,000 sh	$34.00	$340,000	−8.9%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	25/01/02	25/01/06	1,241 sh	$24.68	$30,627.88	−1.2%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	24/10/01	24/10/02	385 sh	$23.48	$9,039.8	−0.4%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	24/04/01	24/04/03	3,401 sh	$32.12	$109,240.12	−3.1%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	24/01/03	24/01/05	1,907 sh	$26.42	$50,382.94	−2.3%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	23/11/20	23/11/22	10,000 sh2 trades	$30.50avg.	$305,000	−10.8%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	23/10/02	23/10/04	388 sh	$22.85	$8,865.8	−0.5%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	23/04/03–23/04/04	23/04/05	2,092 sh2 trades	$29.63avg.	$61,992.1	−2.5%